Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users, Florida and Georgia, 2013-2015 (ICPSR 39792)
Version Date: Apr 22, 2026 View help for published
Principal Investigator(s): View help for Principal Investigator(s)
Lisa R. Metsch, Columbia University;
Daniel J. Feaster, University of Miami;
Carlos del Rio, Emory University
Series:
https://doi.org/10.3886/ICPSR39792.v1
Version V1
Alternate Title View help for Alternate Title
Summary View help for Summary
This Fast Release study is part of the Seek, Test, Treat and Retain (STTR) Collaboration Project, which involved over twenty studies in the fields of HIV and drug abuse. All files in the compressed zip package are released as deposited by the PI and were not further processed.
This study evaluated the efficacy of an integrated "Retention Clinic" in achieving virologic suppression among HIV-infected cocaine users.
Citation View help for Citation
Export Citation:
Funding View help for Funding
Subject Terms View help for Subject Terms
Geographic Coverage View help for Geographic Coverage
Restrictions View help for Restrictions
Users are reminded that these data are to be used solely for statistical analysis and reporting of aggregated information, and not for the investigation of specific individuals or organizations.
Access to the data is restricted. Users interested in obtaining these data must complete a Restricted Data Use Agreement. Data are provided via ICPSR's Virtual Data Enclave (VDE). Apply for access to these data through the ICPSR VDE portal. Information and instructions are available within the data portal. For further assistance please reference the VDE Guide to learn about the application process, about using the VDE, and how to request disclosure review of VDE output.
Distributor(s) View help for Distributor(s)
Time Period(s) View help for Time Period(s)
Date of Collection View help for Date of Collection
Data Collection Notes View help for Data Collection Notes
-
This release is a Fast Track Release. Users should consult the investigator(s) if further information is needed.
-
This study includes baseline and longitudinal data files, study summary, and study data documentation.
Study Purpose View help for Study Purpose
The purpose of this study was to evaluate the efficacy of an integrated "Retention Clinic" in achieving virologic suppression among HIV-infected cocaine users.
Study Design View help for Study Design
This study was a two-group randomized, prospective trial. HIV-infected individuals who report having used cocaine in the 3 months prior to enrollment were eligible. Consented participants were randomized to one of the following two groups: 1) "Retention Clinic" or 2) Treatment as Usual. All participants were provided informed consent and completed a baseline audio computer-assisted self-interview or ACASI focusing on drug use, mental health, demographics and socio-economic factors, HIV care, and drug treatment history as well as blood draws for viral load and CD4 count, and urine collection for toxicology screening. The "Retention Clinic" group received up to 11 Patient Navigator sessions over a 6-month period and 9 sessions of substance abuse treatment over a 3-month period. Follow-up assessments consisted of both ACASI and specimen collection (blood and urine) in all groups were conducted at 6 and 12 months post-randomization. Medical records were reviewed to document use of HIV care, drug treatment, and mental health services during the study period.
Sample View help for Sample
Study participants were recruited from neighborhoods with high rates of HIV and substance abuse, referred to the study teams from community agencies, clinics/medical facilities and treatment programs/centers, and recruited from local hospitals/clinics.
Randomization was stratified at each site by gender equally between intervention and TAU conditions. To obtain the randomization assignment, a member of the site staff called the central Data Manager or Project Manager/Coordinator at their respective sites.
Time Method View help for Time Method
Universe View help for Universe
HIV-infected cocaine users
Unit(s) of Observation View help for Unit(s) of Observation
Data Source View help for Data Source
Data was collected via ACASI and medical record abstraction, blood draws (labs).
Data Type(s) View help for Data Type(s)
Mode of Data Collection View help for Mode of Data Collection
Response Rates View help for Response Rates
A total of 360 HIV-infected individuals who report cocaine use were randomized, with approximately 180 from each site (Miami, FL and Atlanta, GA), into either the intervention ("Retention Clinic") or Treatment As Usual group, and followed-up at 6 and 12 months post randomization to measure CD4 and viral load counts and other data.
HideNotes
The public-use data files in this collection are available for access by the general public. Access does not require affiliation with an ICPSR member institution.
ICPSR usually offers files in multiple formats for researchers to be able to access data and documentation in formats that work well within their needs. If you have questions about the accessibility of materials distributed by ICPSR or require further assistance, please visit ICPSR’s Accessibility Center.
One or more files in this data collection have special restrictions. Restricted data files are not available for direct download from the website; click on the Restricted Data button to learn more.
